Clinical trial

Does Simvastatin Affect Insulin Sensitivity in Dyslipidemic Type 2 Diabetic Patients?

NCT00704314

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-10-01

PhaseNA

Study timeline

Study start (unknown)2002-10-01Date precision: month

Registry last updated2008-06-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Hypercholesterolemiaunresolved

Diabetesunresolved

Cardiovascular Diseaseunresolved

Interventions

SimvastatinDRUG · verified · RxNorm: simvastatin

Sponsors & collaborators

Medical University of Viennalead sponsor

Austrian Science Fund (FWF)collaborator

European Foundation for the Study of Diabetescollaborator

EU grantcollaborator

Merck Sharp & Dohme LLCcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00704314 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.